Young Li
Stock Analyst at Jefferies
(0.63)
# 4,102
Out of 5,105 analysts
7
Total ratings
50%
Success rate
-18.16%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Initiates: Buy | $145 | $126.79 | +14.36% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $12.62 | -28.68% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $82.08 | +40.11% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.00 | +25.51% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $26.47 | +126.67% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $9.56 | +381.17% | 1 | Jul 16, 2021 |
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $126.79
Upside: +14.36%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $12.62
Upside: -28.68%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $82.08
Upside: +40.11%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.00
Upside: +25.51%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $26.47
Upside: +126.67%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $9.56
Upside: +381.17%